Public Sector Pension Investment Board Raises Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Public Sector Pension Investment Board increased its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 15.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 51,854 shares of the medical instruments supplier's stock after acquiring an additional 6,800 shares during the quarter. Public Sector Pension Investment Board owned approximately 0.21% of ICU Medical worth $9,449,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ICUI. Hexagon Capital Partners LLC raised its position in shares of ICU Medical by 162.7% in the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock worth $36,000 after acquiring an additional 122 shares in the last quarter. Allworth Financial LP lifted its position in shares of ICU Medical by 100.0% during the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock valued at $36,000 after buying an additional 100 shares during the last quarter. Innealta Capital LLC bought a new stake in shares of ICU Medical in the 2nd quarter valued at about $32,000. Venturi Wealth Management LLC grew its position in shares of ICU Medical by 1,510.0% in the 3rd quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock worth $59,000 after buying an additional 302 shares during the last quarter. Finally, Russell Investments Group Ltd. grew its position in shares of ICU Medical by 46.4% in the 1st quarter. Russell Investments Group Ltd. now owns 546 shares of the medical instruments supplier's stock worth $59,000 after buying an additional 173 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ICUI shares. KeyCorp increased their target price on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. Raymond James raised their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a research report on Thursday, September 12th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a report on Wednesday, November 20th. Finally, Jefferies Financial Group started coverage on shares of ICU Medical in a report on Monday, October 14th. They set a "hold" rating and a $183.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $173.00.

ICU Medical Stock Performance

ICU Medical stock traded up $4.21 during trading hours on Friday, hitting $163.96. 159,148 shares of the stock traded hands, compared to its average volume of 274,156. The firm's 50 day moving average price is $174.60 and its 200-day moving average price is $147.08. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a market capitalization of $4.01 billion, a price-to-earnings ratio of -35.88 and a beta of 0.66. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26.

Insider Activity

In related news, CEO Vivek Jain sold 12,000 shares of the firm's stock in a transaction dated Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total transaction of $2,141,520.00. Following the sale, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $18,665,666.78. This trade represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Christian B. Voigtlander sold 1,962 shares of ICU Medical stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $169.08, for a total value of $331,734.96. The disclosure for this sale can be found here. Insiders have sold 40,364 shares of company stock valued at $6,876,478 in the last ninety days. Insiders own 6.70% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.